FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation

FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation  FDA.gov FDA Approves Inhaled Amikacin for Non-TB Lung Infection  MedPage Today Insmed's treatment-resistant lung disease drug gets FDA approval  ReutersFull coverage

from Health - Google News https://ift.tt/2OYdQ4r